RAMESH SOMEPALLI: Open Payments
NPI 1689699811 · YANKTON, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$530 in 13 payments from 7 companies in 2025. Trend: 2023 $229 · 2024 $286 · 2025 $530
Food & beverage: $380Honoraria: $150
| Company | Payments | Amount |
|---|---|---|
| H2-Pharma, LLC | 1 | $150 |
| Alkermes, Inc. | 5 | $128 |
| Neurocrine BioSciences, Inc. | 1 | $125 |
| E.R. Squibb & Sons, L.L.C. | 2 | $45 |
| Teva Pharmaceuticals USA, Inc. | 2 | $36 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
Products named: INGREZZA, ARISTADA, COBENFY, UZEDY, FANAPT, SPRAVATO, LYBALVI.
Industry payments across SD — which companies pay providers there.
